Soleno Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $91,730 | $66,018 | $32,657 | $0 |
Gross Profit | 90,867 | 64,876 | 31,961 | |
EBITDA | 45,216 | 27,905 | -2,830 | -41,908 |
EBIT | 44,707 | 27,403 | -3,332 | -42,412 |
Net Income | 43,358 | 26,013 | -4,708 | -43,773 |
Net Change In Cash | 91,730 | 66,018 | 32,657 | 0 |
Free Cash Flow | 48,646 | 43,631 | -12,617 | -32,757 |
Cash | 70,106 | 246,662 | 76,497 | 81,331 |
Basic Shares | 54,331 | 54,921 | 50,483 | 46,179 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $190,405 | $0 | $0 | $0 |
Gross Profit | 187,705 | -1,987 | -1,958 | -2,210 |
EBITDA | 28,383 | -173,632 | -37,030 | -22,103 |
EBIT | 26,366 | -175,619 | -38,988 | -24,067 |
Net Income | 20,890 | -175,850 | -38,988 | -24,067 |
Net Change In Cash | 190,405 | 0 | 0 | 0 |
Free Cash Flow | 46,725 | -69,314 | -24,940 | -20,794 |
Cash | 70,106 | 87,928 | 169,681 | 14,602 |
Basic Shares | 54,331 | 40,175 | 16,492 | 8,397 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.80 |
2025-09-30 | $0.47 |
2025-06-30 | -$0.09 |
2025-03-31 | -$0.95 |
